Rephonic
Artwork for BioVenture VoiCes

BioVenture VoiCes with Chris Garabedian

BiotechTV
Venture Capital
Biotechnology
Biotech
Drug Development
Life Sciences
Scion Life Sciences
Pharmaceutical Industry
Biotech Venture Capital
Clinical Trials
AI In Healthcare
Oncology
Harvard University
Entrepreneurship
Apple Tree Partners
Biopharma
Public Health
Genentech
MIT
Human Genome Project
Pharmaceuticals

Hosted by Chris Garabedian, meet the leading Voices in the BioVenture community and hear their insights and perspectives on the challenges and successes with VC investing.

PublishesTwice monthlyEpisodes48Founded2 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BioVenture VoiCes

Latest Episodes

Blackstone's Senior Managing Director Kiran Reddy describes his early life and education, and the impact that patient care has had on his approach to investing. He describes notable investments in neuroscience, and a stop at Biogen, before returning ... more

Andrew Lam describes his career journey that started with a Doctor of Pharmacy education before working in industry, the investment world, back in industry, and then settling at Ally Bridge. He discusses the successful investments Ally Bridge has mad... more

BT Slingsby describes his education and career abroad, which ultimately led him to found and manage the largest life sciences VC firm in Japan, Catalys Pacific. He describes the dual role of taking assets from Japan and building companies around them... more

George Petrocheilos describes going to school at Hopkins and the relationships formed there that would ultimately lead down the road to specializing in healthcare investing. He discusses starting in life sciences investing at Camden Partners, and the... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Kiran Reddy
Senior Managing Director, Blackstone Life Sciences
Blackstone Life Sciences
Episode: Episode 48: Blackstone's Kiran Reddy
Andrew Lam
Managing Director, Head of Biotech Private Equity at Ally Bridge
Ally Bridge
Episode: Episode 47: Ally Bridge's Andrew Lam
BT Slingsby
Founder and Managing Director, Catalys Pacific
Catalys Pacific
Episode: Episode 46: Catalys Pacific's BT Slingsby
George Petrocheilos
Co-founder and co-managing partner of Catalio Capital
Catalio Capital
Episode: Episode 45: Catalio Capital Management's George Petrocheilos
Adam Koppel
Partner at Bain Life Sciences
Bain Capital Life Sciences
Episode: Episode 44: BainCapital's Adam Koppel
Mike Carusi
Managing Partner at Lightstone Ventures
Lightstone Ventures
Episode: Episode 43: Lightstone Venture's Mike Carusi
Thilo Schroeder
Managing Partner at Nextech
Nextech
Episode: Episode 42: Nextech's Thilo Schroeder
Nanna Lüneborg
General partner at Forbion, former Novo Holdings/ Novo Seeds executive
Forbion
Episode: Episode 41: Forbion's Nanna Lüneborg
Krishna Yeshwant
Managing Partner, Google Ventures (GV)
Google Ventures (GV)
Episode: Episode 40: GV's Krishna Yeshwant

Host

Chris Garabedian
Host of BioVenture VoiCes

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Episode 48: Blackstone's Kiran Reddy
Q: How do you view the evolution of private capital in life sciences and the role of scale capital in late-stage development?
The guest notes that private equity and large pools of capital are increasingly essential to fund phase three and commercialization, as public markets alone cannot sustain the capital needs of mature life science assets. He emphasizes the integration of operating expertise with capital, the benefits of diversified tools (royalties, structured credit, equity), and the ability to support companies with strategic financing to reach meaningful patient impact.
Episode 48: Blackstone's Kiran Reddy
Q: What shaped your decision to move from Third Rock into larger platforms and eventually Blackstone Life Sciences?
He explains that the drive came from a desire to work on later-stage development, clinical strategy, and broad portfolio management, rather than early discovery alone. Joining Biogen provided a learning platform for late-stage development, while Clarus and Praxis allowed him to build a scalable, systems-based approach to company creation; Blackstone offered the scale to execute large, capital-intensive strategies across assets.
Episode 48: Blackstone's Kiran Reddy
Q: Not necessarily Blackstone, that can be part of it. But how would you describe who Kiran Reddy is to someone new in the industry?
Kiran describes himself as a physician focused on bringing new medicines to patients, combining clinical practice with translational medicine and a strong interest in how policy, economics, and biology intersect to create viable medicines. He emphasizes his path from medicine to venture creation, and how operating experience informs his investing and company-building decisions.
Episode 46: Catalys Pacific's BT Slingsby
Q: What role does Excellus play in your portfolio, and how is development structured within Japan?
Excellus serves as a platform in Japan focused on inbound assets, handling clinical development and commercialization to bring US/European products to Japanese patients, enabling a hub-and-spoke style support for portfolio companies and aligning development with regional access goals.
Episode 46: Catalys Pacific's BT Slingsby
Q: How did Catalys Pacific come into existence and what gap was it meant to fill in Japanese biotech?
Catalys Pacific emerged from a desire to stimulate Japanese biotech by spinning out Japanese assets into global companies and creating a development-focused model similar to GHIT, anchored by Takeda and later joined by others, with SoftBank as a key investor, to accelerate global development and access.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioVenture VoiCes

What is BioVenture VoiCes about and what kind of topics does it cover?

Listeners are likely professionals in life sciences, biotech venture capital, and biotech company development who tune in for firsthand insights from investors, founders, and operators shaping biotech funding and strategy. Episodes consistently center on cross-border investing, early-stage company-building, and the evolving biotech funding landscape, with a strong emphasis on cross-disciplinary collaboration, AI-enabled drug discovery, and strategic partnerships with pharma. Noteworthy traits include a clear focus on practical pathways to translating science into patient-ready therapies, deep-dive career journeys of top biotech investors, and a founder-turned-investor lens that helps attendees understand how to source, evaluate, and support... more

Where can I find podcast stats for BioVenture VoiCes?

Rephonic provides a wide range of podcast stats for BioVenture VoiCes. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioVenture VoiCes and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioVenture VoiCes get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for BioVenture VoiCes, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioVenture VoiCes?

Rephonic provides comprehensive predictive audience data for BioVenture VoiCes, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioVenture VoiCes have?

To see how many followers or subscribers BioVenture VoiCes has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioVenture VoiCes?

These podcasts share a similar audience with BioVenture VoiCes:

1. Biotech Hangout
2. The Long Run with Luke Timmerman
3. BioCentury This Week
4. The Readout Loud
5. BiotechTV - News

How many episodes of BioVenture VoiCes are there?

BioVenture VoiCes launched 2 years ago and published 48 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioVenture VoiCes?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioVenture VoiCes?

Rephonic pulls ratings and reviews for BioVenture VoiCes from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioVenture VoiCes?

Rephonic provides full transcripts for episodes of BioVenture VoiCes. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioVenture VoiCes?

Recent guests on BioVenture VoiCes include:

1. Kiran Reddy
2. Andrew Lam
3. BT Slingsby
4. George Petrocheilos
5. Adam Koppel
6. Mike Carusi
7. Thilo Schroeder
8. Nanna Lüneborg

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days